Investigating how a specific protein affects cancer and cardiovascular diseases
Official title: Administrative Supplement for Equipment Purchase
Funded at Utah State University · NIH-11032548 · Data updated 2026-11-12
This study is looking at a protein called PRMT1 to see how it affects diseases like cancer and heart problems, with the goal of finding better treatments that could help patients feel better.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State University NIH-funded |
| Lab location | 1 site (Logan, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $90,241 |
| NIH project number | 3R15GM150121-01S1 |
| Project ID | NIH-11032548 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from cancer or cardiovascular disorders.
✕Less likely to help
Patients with conditions unrelated to PRMT1 or those not affected by cancer or cardiovascular diseases may not benefit from this research.
What this research studies
This research focuses on understanding the role of Protein arginine methyltransferase 1 (PRMT1) in various diseases, including cancer and cardiovascular disorders. By examining how changes in the protein's structure and activity influence its function, the study aims to develop targeted therapies. The researchers will use advanced techniques to analyze the behavior of PRMT1 in cells, which could lead to new treatment strategies for conditions linked to this protein. Patients may benefit from insights that could improve therapeutic approaches for their diseases.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for cancer and cardiovascular diseases by targeting PRMT1.
How similar studies have gone: Previous research has shown promise in targeting similar proteins for therapeutic interventions, indicating potential success for this approach.
Where this research is happening
-
Utah State University
Logan, United States Active
Researchers
- Principal investigator: Hevel, Joan M — Utah State University
- Study coordinator: Hevel, Joan M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.